Average Insider

Where insiders trade, we follow

52W Low$28.66
Current$74.8974.2% above low, 25.8% below high
52W High$91.00

Filing Information

Accession Number0001193125-26-256013
Form Type4
Filing DateJun 3, 2026
DocumentView SEC Filing
Transactions
7
Total Shares
76,682
Total Value
$2,037,092.96
P&L
+112.6% (+$48,794.10)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Common Stock
โ€”Jun 1, 2026Exercise/Conversion25,000$8.27$206,750.0033,977Directโ€”View Details
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Common Stock
โ€”Jun 1, 2026Sale21,069$70.11$1,477,080.1712,908Directโ€”View Details
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Common Stock
โ€”Jun 1, 2026Sale3,931$70.75$278,103.318,977Directโ€”View Details
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Common Stock
โ€”Jun 1, 2026Grant/Award615$70.44$43,320.609,592Directโ€”View Details
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Common Stock
โ€”Jun 1, 2026Grant/Award615$0.00$0.0010,207Directโ€”View Details
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Common Stock
โ€”Jun 2, 2026Tax Withholding452$70.44$31,838.889,755Directโ€”View Details
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Stock option (right to buy)
(Common Stock)
DerivativeJun 1, 2026Exercise/Conversion25,000$0.00$0.00141,986Directโ€”View Details
Version: v26.5.2